S&P 500

5.431,60

-0,04%

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

Startseite
Investieren
Aktien
USA
USOTC
Biovaxys Technology Corporation (PK) (BVAXF)
Biovaxys Technology Corporation (PK) (BVAXF) News

BVAXF

Biovaxys Technology (PK) (BVAXF)

Biovaxys Technology Corporation (PK)

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:BVAXF

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
29/08/2022	22h52	Edgar (US Regulatory)	Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)	USOTC:BVAXF	Biovaxys Technology Corporation (PK)
10/08/2022	15h05	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:BVAXF	Biovaxys Technology Corporation (PK)
08/06/2022	12h28	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:BVAXF	Biovaxys Technology Corporation (PK)
03/06/2022	22h06	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:BVAXF	Biovaxys Technology Corporation (PK)
18/05/2022	12h28	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:BVAXF	Biovaxys Technology Corporation (PK)
13/05/2022	13h49	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:BVAXF	Biovaxys Technology Corporation (PK)
12/04/2022	22h16	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:BVAXF	Biovaxys Technology Corporation (PK)
08/04/2022	14h01	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:BVAXF	Biovaxys Technology Corporation (PK)
04/04/2022	23h20	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:BVAXF	Biovaxys Technology Corporation (PK)
04/04/2022	13h09	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:BVAXF	Biovaxys Technology Corporation (PK)
28/03/2022	12h53	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	USOTC:BVAXF	Biovaxys Technology Corporation (PK)
11/01/2022	18h47	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:BVAXF	Biovaxys Technology Corporation (PK)
30/12/2021	22h16	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:BVAXF	Biovaxys Technology Corporation (PK)
29/12/2021	12h08	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:BVAXF	Biovaxys Technology Corporation (PK)
28/12/2021	23h21	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	USOTC:BVAXF	Biovaxys Technology Corporation (PK)
27/12/2021	22h16	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:BVAXF	Biovaxys Technology Corporation (PK)
27/12/2021	12h38	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	USOTC:BVAXF	Biovaxys Technology Corporation (PK)
22/12/2021	22h15	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:BVAXF	Biovaxys Technology Corporation (PK)
13/12/2021	13h35	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:BVAXF	Biovaxys Technology Corporation (PK)
02/12/2021	22h15	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:BVAXF	Biovaxys Technology Corporation (PK)
24/11/2021	21h07	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:BVAXF	Biovaxys Technology Corporation (PK)
22/11/2021	12h06	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:BVAXF	Biovaxys Technology Corporation (PK)
12/11/2021	14h23	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:BVAXF	Biovaxys Technology Corporation (PK)
25/10/2021	12h05	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:BVAXF	Biovaxys Technology Corporation (PK)